|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-04
|
$165,747
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
|
5R01CA205975-03
|
$386,619
|
GHAFFARI, SAGHI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
5R01CA216273-02
|
$740,321
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-04
|
$640,378
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-04
|
$525,066
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-04
|
$681,586
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202924-02
|
$229,982
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221697-01
|
$324,559
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-03S1
|
$63,140
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-03
|
$288,919
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-04
|
$158,966
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-02
|
$255,626
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-08
|
$1,192,222
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221696-01
|
$221,442
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
1R01CA218356-01
|
$620,500
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120 02060
|
$79,723
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia
|
2R01CA174844-04
|
$575,010
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-04
|
$311,458
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$151,467
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-05
|
$533,845
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel genetic pathway for survival of B-lymphoblastic leukemia-initiating cells
|
1R21CA209298-01A1
|
$218,588
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
|
1R41CA228622-01
|
$298,305
|
NGUYEN, HIEN-ANH
|
ENZYME BY DESIGN, INC.
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
5R00CA183914-05
|
$148,607
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
5R01CA201719-03
|
$361,510
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
A Paradigm Shift in Chronic Lymphocytic Leukemia: Defining the Role of Hematopoietic Stem Cells in Leukemogenesis
|
1F30CA225070-01A1
|
$38,725
|
HU, EILEEN
|
OHIO STATE UNIVERSITY
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
3R44CA221513-02S1
|
$4,319
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
5R44CA221513-02
|
$982,509
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-03
|
$590,572
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A rapid spontaneous murine model of CN-AML
|
3R01CA196658-03S1
|
$219,775
|
GRIMES, H
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A rapid spontaneous murine model of CN-AML
|
5R01CA196658-03
|
$567,086
|
GRIMES, H
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$305,473
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-02
|
$88,993
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
1R21CA204708-01A1
|
$227,675
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
Sinha, Rashmi
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|